# A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes

> **NCT02008851** · PHASE1 · TERMINATED · sponsor: **Tengion** · enrollment: 1 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **BIOLOGICAL:** Neo-kidney augment

## Key facts

- **NCT ID:** NCT02008851
- **Lead sponsor:** Tengion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2014-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02008851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02008851, "A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02008851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*